ENVISION-ENERGY
3.5.2016 10:01:57 CEST | Business Wire | Press release
Envision, one of the world’s leading renewable energy and technology companies, today announced the acquisition of Norway-based BazeField technology in a partnership that will drive both companies forward in the digital energy revolution.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160503005810/en/
The partnership with BazeField is a continuation of Envision’s commitment to cooperate with the best companies around the world to develop solutions to meet global energy and climate challenges, and enable the necessary transition to a low-carbon global economy.
“BazeField is at the cutting edge of renewable energy system management technology,” said Felix Zhang, Envision executive director. “The acquisition will provide the resources and support for BazeField to further develop its state-of-the-art technology, and provide better products and services to its global clients. The synergies and complementary technologies between Envision and BazeField will create a partnership that will drive forward growth and innovation for both companies.”
According to Zhang, the digital energy technology market is at an early stage of development, fragmented and geographically diverse. “At this stage of the market’s development, innovation and growth requires more partnerships and greater cooperation,” he said. “The new relationship between Envision and BazeField will play a key part in achieving those goals and pushing the market forward.”
BazeField will continue to operate independently under the agreement. “The independence of BazeField is important for the success of this partnership,” Zhang said. “With Bazefield operating independently, customers will have more choice and BazeField will have the autonomy it needs to continue its development efforts.”
“We decided we would need a partner to grow with,” said BazeField CEO Sigurd Juvik. “Envision is the right partner for us. The companies have a similar vision for smart energy technology and the partnership offers us the resources and industry insights that will accelerate our product development and entry into new market regions. We have confidence in our technology. Moving forward with Envision Energy is an endorsement of that, and a massive vote of confidence.”
Zhang pointed out that the world is rapidly moving to a future energy system that is completely different from today’s. “This energy future will rely on society and business being able to run an energy system in which digitalisation means greater control and improved efficiency at every juncture,” Zhang said. “Envision Energy and BazeField are at the forefront of this transition, using software to maximise the efficiency of every piece of hardware they help to operate. The global market is undergoing a fundamental paradigm shift and global cooperation is a must.”
After the acquisition is complete, customers will be able to use the same technology platforms they have chosen from Envision or BazeField, but with added innovation and potential. Juvik said, “The combination of BazeField and Envision Energy will accelerate investment in BazeField’s technology, increase both companies’ rate of growth and geographic expansion, and increase employment and investment in Norway and Europe, all of which will help us overcome the challenges we face today in energy and the environment.”
About Envision Energy
Envision Energy (www.envision-energy.com ) is one of the world's largest smart energy management companies and among the eight largest turbine companies in the world with more than 7.5 GW of Envision smart wind turbines in operation. Envision's Energy OS platform is used to manage more than 50 GW of renewable energy assets, including charging stations and energy consumption devices worldwide. Envision has regional offices across Asia, Europe, North and South America and has established global R&D and engineering centers in Denmark, Germany and the United States.
About BazeField
Baze Technology is a software company headquartered in Norway. It’s industry leading product, BazeField Wind, is a turbine independent Wind Farm Management System (WFMS) that provides tools for real-time monitoring, reporting, availability planning, stop and loss analysis and fact-based decision making. BazeField’s Wind Farm Management System includes turnkey interfaces such as: turbine SCADA, grid, met, forecasts, trading systems etc. It also includes a suite of monitoring, analysis and operations management applications, KPI's measurements and reports needed for support in O&M of wind farms.
Envision Energy/BazeField
Transaction Summary
Purpose of the deal
With the partnership with BazeField, Envision Energy continues to cooperate with the best companies around the world to develop solutions to meet the global energy and climate challenges.
Envision Energy
Founded: 2007
HQ: Registered in Hong Kong
Employees: More than 1,000 renewable energy and software development professionals working in 12 countries.
Market position in global renewables energy and technology market:
- Second largest wind turbine company in China
- A top-10 wind turbine technology provider in the world
- Developed a leading lifecycle management system that features smart sensor networks and cloud-based IT infrastructure designed to create smart wind farms
- Largest smart energy management company in the world, currently managing more than 50 million kilowatts of global alternative energy assets
- Largest offshore turbine supplier in China
- Current markets: China, UK, Mexico, Chile, Denmark (R&D), Germany (R&D), US (R&D, System Management)
Products/Services
Wind turbines and systems
Solar power software systems
Smart energy management technology
Many other digital energy solutions
Executives
Zhang Lei - Chief Executive Officer
Felix Zhang - Executive Director
Tim Naylor - Head of Software Sales in Europe
Tim Hertel - Head of Software Sales in North America
John Childs - Head of Turbine Business Development for Europe Middle East & Africa
Michael Friedrich - Chief System Engineer
Mathias Mier - Director of Technology & Quality
Markets
Envision in North America/South America – Aerodynamics R&D, global digital energy centre and innovation lab, Envision Ventures
Envision in Europe – 1 global innovation centres
Envision in APAC – Global manufacturing, R&D, international project CoE business operations and smart energy software R&D
BazeField
Founded: 2007 as a spin-off from CARDIAC AS
HQ: Porsgrunn, Norway
Products/Services
BazeField Wind is a turbine independent Wind Farm Management System (WFMS) that provides tools for real-time monitoring, reporting, availability planning, stop and loss analysis, and fact-based decision-making. Approximately 7 GW of installed wind power capacity are managed on a daily basis.
Executives
Sigurd J. Juvik – Chief Executive Officer
Tor-Egil Tinderholt – Chief Financial Officer/Chief Operating Officer
Thorstein Rinker – Vice President Business Development
John Båserud – Chief Technology Officer
View source version on businesswire.com: http://www.businesswire.com/news/home/20160503005810/en/
Contact:
For Envision Energy:
UK
Stephanie Bailey, +44
(0) 208 618 2809
Press office
Stephanie.bailey@fhflondon.co.uk
or
Norway
Rune
Mørck Wergeland, +47 913 88 914
Press office
rmw@wask.no
or
Brussels
Alexandria
Hicks, +32 470 904 333
Press office
alexandria.hicks@fleishmaneurope.com
or
San
Francisco
Yang Stratton, 650-564-5036
yang.stratton@envision-energy.com
or
Houston
-
Joe Brettell, +1713-513-9511
Press office
joe.brettell@fleishman.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom